d-Serine Intervention In The Medial Entorhinal Area Alters TLE-Related Pathology In CA1 Hippocampus Via The Temporoammonic Pathway

• Published in: Neuroscience Vol. 453; pp. 168 - 186
• Main Authors: Beesley, Stephen, Sullenberger, Thomas, Ailani, Roshan, D'Orio, Cameron, Crockett, Mathew S., Kumar, Sanjay S.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Ltd 15.01.2021
• Subjects: Animals; d-Serine intervention; Entorhinal Cortex; Epilepsy, Temporal Lobe - drug therapy; Hippocampus; Neurodegeneration; Perforant pathway; Pilocarpine; Rats; Serine; Temporal lobe epilepsy; Temporoammonic pathway; PP; t-NMDARs; TAP; d-Serine intervention; DG; Temporoammonic pathway; Neurodegeneration; Perforant pathway; MEA; LEA; Temporal lobe epilepsy; Hippocampus
• ISSN: 0306-4522; 1873-7544
• DOI: 10.1016/j.neuroscience.2020.10.025

[Display omitted] •TLE related pathology in MEA influences neuron loss and gliosis in the hippocampus.•The CA1c region is the most susceptible of the three subdivisions of CA1.•Intervention in MEA with d-serine mitigated hippocampal pathology.•Entrainment of the hippocampus in TLE is mediated via the temporoammonic pathway.•This work is of relevance to TLE-related neurodegeneration and neuroinflammation. Entrainment of the hippocampus by the medial entorhinal area (MEA) in Temporal Lobe Epilepsy (TLE), the most common type of drug-resistant epilepsy in adults, is believed to be mediated primarily through the perforant pathway (PP), which connects stellate cells in layer (L) II of the MEA with granule cells of the dentate gyrus (DG) to drive the hippocampal tri-synaptic circuit. Using immunohistochemistry, high-resolution confocal microscopy and the rat pilocarpine model of TLE, we show here that the lesser known temporoammonic pathway (TAP) plays a significant role in transferring MEA pathology to the CA1 region of the hippocampus independently of the PP. The pathology observed was region-specific and restricted primarily to the CA1c subfield of the hippocampus. As shown previously, daily intracranial infusion of d-serine (100 μm), an antagonist of GluN3-containing triheteromeric N-Methyl d-aspartate receptors (t-NMDARs), into the MEA prevented loss of LIII neurons and epileptogenesis. This intervention in the MEA led to the rescue of hippocampal CA1 neurons that would have otherwise perished in the epileptic animals, and down regulation of the expression of astrocytes and microglia thereby mitigating the effects of neuroinflammation. Interestingly, these changes were not observed to a similar extent in other regions of vulnerability like the hilus, DG or CA3, suggesting that the pathology manifest in CA1 is driven predominantly through the TAP. This work highlights TAP’s role in the entrainment of the hippocampus and identifies specific areas for therapeutic intervention in dealing with TLE.